Recall Register

Device recall: Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.

Class II FDA enforcement event 79375. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

The cobas MRSA/SA tests may have decreased performance compared to the analytical sensitivity for MSRA detection. A screening failure can lead to potential infection in the colonized patient being tested as well as the spread of MSRA to others. The United States is not impacted, as the cobas MRSA/SA nucleic acid test for use on the cobas liat system is not available in the US.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Roche Molecular Systems, Inc. started this device recall on 27 Oct 2017. The firm address in the FDA record is in Branchburg, NJ. FDA put the recall in Class II. FDA event 79375 has 1 product record. The first FDA enforcement report date is 4 Apr 2018. The record gives the status Terminated, with the termination date 27 Apr 2020.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution. Austria, Denmark, Germany, Singapore, Netherlands, Hong Kong, and Switzerland. US product is not affected.

Recalling firm

Roche Molecular Systems, Inc., Branchburg, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 79375: product records
Recall numberProductQuantityClassStatusReport date
Z-1195-2018Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.136 kitsClass IITerminated4 Apr 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2017
1,091
Share of these events in Class II
93%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
30

Other events of the firm

Other FDA enforcement events of Roche Molecular Systems, Inc.
InitiatedProduct (first record)TypeClassRecords
21 Dec 2022cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190DeviceClass II3
8 Sep 2022cobas 5800 instrument, Material No. 08707464001. Used for automated Polymerase Chain Reaction (PCR) based Nucleic Acid TDeviceClass II1
16 Nov 2021cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number 07341920190DeviceClass II1
3 Sep 2021cobas EGFR Mutation Test v2-Somatic gene mutation detection system Catalog Number :07248563190DeviceClass II1
4 Aug 2021cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat System, Catalog Number 09211101190DeviceClass II1
25 Mar 2021cobas SARS-CoV-2 & Influenza A/B assay cobas Liat- Reagents, 2019-Novel Coronavirus Nucleic Acid for use on the cobas LiDeviceClass II2
23 Nov 2020uPath software 1.1 and uPath software 1.1 IVD-INSW, Material numbers 08991871001 and 09077332001DeviceClass II1
19 Nov 2020The cobas z 480 analyzer including dedicated software for IVD use is a plate-based automated amplification and detectionDeviceClass II1
3 Jun 2020MagNA Pure 96 Instrument, clinical sample concentrator, Material number 06541089001 - Product Usage: This protocol is inDeviceClass II1
2 May 2018MagNA Pure 24 System, GMMI: 07290519001 Product Usage: The MagNA Pure 24 System is a fully automated clinical sample extDeviceClass II1

Roche Molecular Systems, Inc.: all 30 events

Official channels

Cite this page

Recall Register. FDA enforcement event 79375. https://recallregister.com/fda/ii/79375/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution. Austria, Denmark, Germany, Singapore, Netherlands, Hong Kong, and Switzerland. US product is not affected.
What quantity of product is in FDA event 79375?
The FDA record gives this quantity: 136 kits
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2017 have the same class?
93% of the 1,091 device events that started in 2017 are in Class II.